Corcept Therapeutics Inc (CORT) stock
CORTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 11/30537% above fair value
$70.07+0.85 (+1.23%)
Close on Nov 17, 2026Market cap $7.57BP/E 166.8Yield –
Corcept Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Corcept Therapeutics's price to book ratio was 12.2× on Nov 11, 2026, against 15.0× a year earlier. Over the last 5 years it ranged from 4.4× to 20.8×, with a median of 7.6×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 12.2× | +5.6 |
| 2025 | Dec 31, 2025 | 6.6× | −2.2 |
| 2024 | Dec 31, 2024 | 8.8× | +0.8 |
| 2023 | Dec 29, 2023 | 8.0× | +2.9 |
| 2022 | Dec 30, 2022 | 5.0× | +0.4 |
| 2021 | Dec 31, 2021 | 4.7× | −1.9 |
| 2020 | Dec 31, 2020 | 6.6× | +2.1 |
| 2019 | Dec 31, 2019 | 4.5× | −2.1 |
| 2018 | Dec 31, 2018 | 6.6× | −17.3 |
| 2017 | Dec 29, 2017 | 23.9× | −1.9 |
| 2016 | Dec 30, 2016 | 25.8× | −14.4 |
| 2015 | Dec 31, 2015 | 40.2× | −55.0 |
| 2014 | Oct 31, 2014 | 95.2× | +84.8 |
| 2013 | Dec 31, 2013 | 10.4× | +8.6 |
| 2012 | Dec 31, 2012 | 1.8× | −10.4 |
| 2011 | Jul 29, 2011 | 12.2× | – |
See a number that looks wrong?